• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Cannabis Stock Gainers And Losers From July 15, 2024

    7/15/24 4:30:05 PM ET
    $CARA
    $CGC
    $EAST
    $GENE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $CARA alert in real time by email

    GAINERS:

    • Australis Capital (OTC:AUSAF) shares closed up 9900.00% at $0.01
    • Global Hemp Group (OTC:GBHPF) shares closed up 70.36% at $0.05
    • Maple Leaf Green World (OTC:MGWFF) shares closed up 68.48% at $0.05
    • CordovaCann (OTC:LVRLF) shares closed up 42.50% at $0.06
    • Target Group (OTC:CBDY) shares closed up 25.00% at $0.00
    • Blueberries Medical (OTC:BBRRF) shares closed up 19.09% at $0.01
    • CLS Holdings USA (OTC:CLSH) shares closed up 17.00% at $0.04
    • Zelira Therapeutics (OTC:ZLDAF) shares closed up 15.32% at $0.55
    • Leafbuyer Techs (OTC:LBUY) shares closed up 14.67% at $0.02
    • Canopy Gwth (NASDAQ:CGC) shares closed up 10.92% at $7.14
    • SOL Glb Inv (OTC:SOLCF) shares closed up 10.66% at $0.05
    • Cansortium (OTC:CNTMF) shares closed up 9.71% at $0.11
    • Rocky Mountain High (OTC:RMHB) shares closed up 7.69% at $0.01
    • Genetic Technologies (NASDAQ:GENE) shares closed up 6.89% at $0.92
    • Affinor Growers (OTC:RSSFF) shares closed up 6.05% at $0.07
    • GrowGeneration (NASDAQ:GRWG) shares closed up 5.15% at $2.47
    • Urban-gro (NASDAQ:UGRO) shares closed up 3.33% at $1.47

    LOSERS:

    • Elixinol Wellness (OTC:ELLXF) shares closed down 20.00% at $0.00
    • Kaya Holdings (OTC:KAYS) shares closed down 18.96% at $0.04
    • Eastside Distilling (NASDAQ:EAST) shares closed down 15.97% at $1.01
    • Body and Mind (OTC:BMMJ) shares closed down 15.83% at $0.03
    • 4Front Ventures (OTC:FFNTF) shares closed down 10.50% at $0.08
    • CNBX Pharmaceuticals (OTC:CNBX) shares closed down 9.86% at $0.01
    • Global Compliance (OTC:FUAPF) shares closed down 7.85% at $0.01
    • CV Sciences (OTC:CVSI) shares closed down 5.21% at $0.05
    • MariMed (OTC:MRMD) shares closed down 4.12% at $0.16
    • Cara Therapeutics (NASDAQ:CARA) shares closed down 3.17% at $0.34
    • Nextleaf Solutions (OTC:OILFF) shares closed down 3.16% at $0.06

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $CARA alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CARA
    $CGC
    $EAST
    $GENE

    CompanyDatePrice TargetRatingAnalyst
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$6.00 → $1.00Buy → Hold
    Stifel
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$10.00 → $1.00Buy → Hold
    Canaccord Genuity
    Cara Therapeutics Inc.
    $CARA
    6/13/2024Buy → Hold
    Needham
    Cara Therapeutics Inc.
    $CARA
    6/13/2024Buy → Neutral
    H.C. Wainwright
    GrowGeneration Corp.
    $GRWG
    3/20/2024Outperform → Perform
    Oppenheimer
    GrowGeneration Corp.
    $GRWG
    5/10/2023$4.25 → $4.75Hold → Buy
    Craig Hallum
    Canopy Growth Corporation
    $CGC
    4/4/2023Underperform → Mkt Perform
    Bernstein
    Cara Therapeutics Inc.
    $CARA
    3/8/2023$13.00 → $6.00Neutral → Underperform
    BofA Securities
    More analyst ratings

    $CARA
    $CGC
    $EAST
    $GENE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Stewart Thomas Carlton sold $10,036 worth of shares (5,768 units at $1.74), decreasing direct ownership by 8% to 68,203 units (SEC Form 4)

    4 - Canopy Growth Corp (0001737927) (Issuer)

    8/26/25 4:15:57 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Officer Gedeon Christelle sold $29,456 worth of shares (16,929 units at $1.74), decreasing direct ownership by 4% to 368,488 units (SEC Form 4)

    4 - Canopy Growth Corp (0001737927) (Issuer)

    8/26/25 4:15:17 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Officer Gedeon Christelle sold $8,422 worth of shares (4,528 units at $1.86), decreasing direct ownership by 1% to 385,417 units (SEC Form 4)

    4 - Canopy Growth Corp (0001737927) (Issuer)

    8/20/25 4:30:19 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    $CARA
    $CGC
    $EAST
    $GENE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Canopy Growth Establishes New US$200 Million At-The-Market Program to Strengthen the Company's Financial Position

    Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that the Company has established a new at-the-market equity program (the "ATM Program") that allows Canopy Growth to issue and sell up to US$200 million of common shares of the Company ("Common Shares") from treasury from time to time in concurrent public offerings in the United States (the "U.S. Offering") and Canada; provided, however, that (i) sales of Common Shares in the ATM Program in Canada is limited to aggregate gross sales proceeds to the Company of up to US$50 million (or its Canadian

    8/29/25 4:55:00 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Canopy USA Welcomes Cannabis Veteran Eric Ruhle as New Vice President of Brand Sales

    BOULDER, Colo., Aug. 27, 2025 /PRNewswire/ -- Canopy USA, LLC ("Canopy USA"), a brand-driven organization strategically positioned across the U.S. cannabis market, today announced the appointment of Eric Ruhle as Vice President of Brand Sales, overseeing sales strategy across the full Canopy USA portfolio. With more than 11 years of experience in the regulated cannabis industry, Ruhle brings deep expertise in building and leading high-performing sales organizations. Most recently, he served as Senior Regional Sales Manager at Kiva Sales & Services, where he navigated the highl

    8/27/25 8:01:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    GrowGeneration Partners with Arett Sales to Expand Nationwide Distribution of Proprietary Cultivation Brands

    DENVER, Aug. 26, 2025 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ:GRWG) ("GrowGen" or the "Company"), the nation's largest specialty hydroponic and organic gardening retailer, today announced it is expanding its U.S. distribution through a new strategic partnership with Arett Sales, a leading national lawn, garden, and outdoor living distributor. This collaboration marks a major expansion of GrowGeneration's wholesale and B2B strategy, bringing its proprietary cultivation brands into thousands of new retail doors through Arett's 32 state distribution network. Under the distribution agreement, which is set to commence immediately, Arett Sales will distribute GrowGeneration's proprie

    8/26/25 8:00:00 AM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    $CARA
    $CGC
    $EAST
    $GENE
    SEC Filings

    View All

    urban-gro Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Leadership Update, Financial Statements and Exhibits

    8-K - urban-gro, Inc. (0001706524) (Filer)

    9/2/25 5:00:30 PM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    Canopy Growth Corporation filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Canopy Growth Corp (0001737927) (Filer)

    8/29/25 5:03:52 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 424B5 filed by Canopy Growth Corporation

    424B5 - Canopy Growth Corp (0001737927) (Filer)

    8/29/25 4:12:22 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    $CARA
    $CGC
    $EAST
    $GENE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CGC
    $EAST
    $GENE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President Salaman Michael bought $103,413 worth of shares (85,465 units at $1.21), increasing direct ownership by 6% to 1,639,313 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    3/20/25 3:54:41 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    CEO Lampert Darren bought $98,340 worth of shares (82,639 units at $1.19), increasing direct ownership by 5% to 1,728,522 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    3/20/25 3:54:01 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    CEO of Subsidiary Liuzza Nicholas Reyland Jr bought $36,749 worth of shares (45,000 units at $0.82) (SEC Form 4)

    4 - Eastside Distilling, Inc. (0001534708) (Issuer)

    12/11/24 5:18:50 PM ET
    $EAST
    Beverages (Production/Distribution)
    Consumer Staples

    $CARA
    $CGC
    $EAST
    $GENE
    Financials

    Live finance-specific insights

    View All

    GrowGeneration Reports Second Quarter 2025 Financial Results

    Net Sales of $41.0 million, Up 14.7% Sequentially Proprietary Brand Sales Rise to 32.0% of Cultivation and Gardening Revenue Store Operating Expenses Down 22.9% Year-over-Year DENVER, Aug. 11, 2025 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ:GRWG) ("GrowGeneration," "GrowGen," or the "Company"), the nation's largest specialty hydroponic and organic gardening retailer, today announced financial results for the second quarter of 2025. Second Quarter 2025 Summary(1) Net sales of $41.0 million, up 14.7% quarter-over-quarter;Proprietary brand sales as a percentage of Cultivation and Gardening net sales increased to 32.0% compared to 21.5% in the second quarter of 2024;Gross profit mar

    8/11/25 4:05:00 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    Canopy Growth Reports First Quarter Fiscal 2026 Financial Results; Cannabis Revenue Increased 24% Year-Over-Year

     Canada adult-use cannabis Q1 FY2026 net revenue increased 43% year-over-year, benefiting from increased distribution and strong consumer demand for new products, including Claybourne infused pre-roll joints Company has achieved $17MM of planned $20MM annualized savings target since March 1, 2025; SG&A expenses down 21% year-over-year in Q1 FY2026 compared to Q1 FY2025 Supply chain improvements in international markets expected to increase cannabis supply and consistency in margin accretive European markets in the second half of FY2026 Company expects to launch a new Storz & Bickel vaporizer during the second half of the calendar year Canopy Growth Corporation ("Canopy Growth" or th

    8/8/25 7:00:00 AM ET
    $CGC
    $DRI
    Medicinal Chemicals and Botanical Products
    Health Care
    Restaurants
    Consumer Discretionary

    GrowGeneration Schedules Second Quarter 2025 Earnings Release Conference Call for August 11, 2025

    DENVER, July 30, 2025 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ:GRWG) ("GrowGen" or the "Company"), the nation's largest specialty retailer of hydroponic and organic gardening products, today announced it will release its financial results for the second quarter ended June 30, 2025, on Monday, August 11, 2025, after market close. The announcement will be followed by a live earnings conference call at 4:30 p.m. ET. To participate in the call, please dial 1-(888)-699-1199 (domestic) or 1-(416)-945-7677 (international). The conference code is 53471. The call will also be webcast and can be accessed here or in the Investor Relations section of the GrowGeneration website at: ir.growge

    7/30/25 8:00:00 AM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    $CARA
    $CGC
    $EAST
    $GENE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by GrowGeneration Corp.

    SC 13G/A - GrowGeneration Corp. (0001604868) (Subject)

    11/12/24 3:53:28 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by GrowGeneration Corp.

    SC 13G/A - GrowGeneration Corp. (0001604868) (Subject)

    11/4/24 11:51:39 AM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    SEC Form SC 13D filed by Cara Therapeutics Inc.

    SC 13D - Cara Therapeutics, Inc. (0001346830) (Subject)

    10/30/24 4:21:50 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CGC
    $EAST
    $GENE
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at urban-gro Inc. on Jun 6

    Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

    6/10/24 12:49:49 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    $CARA
    $CGC
    $EAST
    $GENE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cara Therapeutics downgraded by Stifel with a new price target

    Stifel downgraded Cara Therapeutics from Buy to Hold and set a new price target of $1.00 from $6.00 previously

    6/13/24 7:05:24 AM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cara Therapeutics downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Cara Therapeutics from Buy to Hold and set a new price target of $1.00 from $10.00 previously

    6/13/24 7:05:04 AM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cara Therapeutics downgraded by Needham

    Needham downgraded Cara Therapeutics from Buy to Hold

    6/13/24 7:04:33 AM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CGC
    $EAST
    $GENE
    Leadership Updates

    Live Leadership Updates

    View All

    Canopy USA Welcomes Cannabis Veteran Eric Ruhle as New Vice President of Brand Sales

    BOULDER, Colo., Aug. 27, 2025 /PRNewswire/ -- Canopy USA, LLC ("Canopy USA"), a brand-driven organization strategically positioned across the U.S. cannabis market, today announced the appointment of Eric Ruhle as Vice President of Brand Sales, overseeing sales strategy across the full Canopy USA portfolio. With more than 11 years of experience in the regulated cannabis industry, Ruhle brings deep expertise in building and leading high-performing sales organizations. Most recently, he served as Senior Regional Sales Manager at Kiva Sales & Services, where he navigated the highl

    8/27/25 8:01:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Canopy USA Appoints New Executive Team to Accelerate Growth Across U.S. Cannabis Market

    New leaders will be responsible for driving portfolio growth, operational improvements, and market expansion BOULDER, Colo., Aug. 18, 2025 /PRNewswire/ -- Canopy USA, LLC ("Canopy USA"), a brand-driven organization strategically positioned across the fastest growing states and highest potential segments of the U.S. cannabis market, today announced the appointment of a new executive team responsible for driving the Company's next phase of expansion. Drawing on extensive industry experience, these leaders will steer Canopy USA forward through a shared vision to elevate the compa

    8/18/25 8:01:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Canopy Growth Announces Mailing and Filing of Proxy Materials for Annual General and Special Meeting and Urges All Shareholders to Vote Now

    Voting is important and easy; shareholders are urged to vote today to help the Company avoid incurring additional costs. Canopy Growth shareholders with a 16-digit control number can vote online at http://proxyvote.com, and by phone at 1-800-474-7493. For more information, shareholders should contact Canopy Growth's strategic shareholder advisor and proxy solicitation agent, Laurel Hill Advisory Group, at 1-877-452-7184 (1‑416‑304‑0211 for collect calls outside North America) or by email at [email protected]. Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED, NASDAQ:CGC) announced today that the Company has mailed (or mailed a notice of internet availa

    8/15/25 7:00:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care